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D. Vella Briffa 
The recently held Ma/taDerm '94 illustrates the 
overlap between contemporary dermatology and 
general medicine, and presents an opportunity to 
review recent developments affecting those 
mundane diseases which are nevertheless 
important because they form the bulk of 
dermatological practice. 
Armed with synthetic antibodies, azelaic acid, 
cyproterone acetate and isotretinoin, the modem 
practitioner can confront the worst case of acne 
vulgaris with equanimity. Old wives' tales about 
fatty foods and chocolates can be confidently 
brushed aside and replaced with scientific 
explanations based upon the iole of androgens, 
sebum production, follicular keratinization and 
proliferation of P. acnes which have been 
unravelled with painstaking research. 
Psoriasis is another major challenge which must 
be confronted daily. Though the aetiology of 
this chronic and cosmetically disabling disease 
remains mysterious, a role for the immune 
system in its pathogenesis now seems certain. 
Concern about toxicity precludes wider usage of 
the highly efficacious cyclosporine, methotrexate 
and etretinate, but psoriatics (who in Malta have 
missed out on PUV A - another major recent 
therapeutic advance) may benefit significantly 
from the launch of ca/cipotriol ointment, a 
synthetic derivative of vitamin D which 
possesses most of the antipsoriatic benefits of 
fluorinated steroids without their troublesome 
side-effects. The incidence of eczema is even 
higher and often symptomatic treatment is all that 
can be offered. The side-effects of topical 
steroids in chronic atopic eczema are well 
recognized, but newer preparations like 
mometasone furoate seem poised to address this 
problem because they combine high potency with 
the safety profile of hydrocortisone and the 
convenience of once daily application. 
The newer, long acting and non-sedating 
antihistamines are a boon in chronic urticaria 
where a remediable cause is rarely found. Other 
more recent symptomatic treatments which do 
seem to make a difference are metronidazole gel 
for acne rosacea and diphenylcyclopropenone 
immunotherapy for alopecia areata. Infections 
of the skin are ubiquitous. Newer anti-viral 
drugs like acyclovir and famciclovir help to 
mitigate the burden of herpes and varicella­
zoster virus infections. The unveiling of the 
oncogenic properties of the human papilloma 
virus was another important achievement. On 
the other hand the wart virus epidemic marches 
on, hardly slowed by traditional destructive 
treatments of dubious merit, whilst newer 
remedies like isoprinosine, podophyllotoxin and 
interferone cream still face the test of time. 
Staphylococcal impetigo and furuncolosis this 
year gave us a .difficult summer, but mupirocin 
ointment seems to be fulfilling its promise as a 
safe and effective standby for properly selected 
cases. Also, the new azole and allylamine oral 
antifungals are proving effective against a wider 
range of pathogenic fungi thus opening up new 
perspetives in the eradication of deep and 
superficial mycotic infections including those of 
the nails, whilst ongoing pharmaco-kinetic 
research points the way to reduced dosage 
regimens for better compliance, wider safety 
margins and lower cost. 
Regrettably, the battle against skin cancer, which 
latter, for the most part is due to excessive sun 
exposure and therefore preventable, is still being 
lost. Hopefully, the revolution in the local 
broadcasting media will pay dividends in the 
future through wider public awareness of risks 
and preventive measures. 
Last, but by no means least, ventures like the 
Psoriasis Association of Malta are helping 
patients to overcome the stigma associated with 
skin disease and to help them help themselves, 
whilst provision of free medicines under 
Schedule V is a welcome relief from the 
financial burden of the malady. 
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